GlassScriptPhysician profile
Rhonda Rubin
NPI 1265420426
$1,252.65
in general payments reported to CMS, 2019-2025
9 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $132 · 2021: $112 · 2022: $112 · 2024: $392 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $367.14 | 2019-2024 | Ozempic |
| Amarin Pharma, INC. | $131.87 | 2020 | |
| Idorsia Pharmaceuticals US INC | $131.25 | 2024 | Quviviq |
| Amgen INC. | $125.00 | 2024 | Otezla |
| Abbott Laboratories | $124.60 | 2019 | |
| Scpharmaceuticals INC. | $121.91 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $114.70 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $111.52 | 2021 | |
| Amneal Pharmaceuticals LLC | $24.66 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhonda Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.